Although further studies are needed to fully elucidate the molecular mechanisms involved in neuroprotective effects of Bxt, this drug appears to be a promising neuroprotective therapy for ALS, especially for those cases related to SOD1 mutations. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.